Stifel Financial’s Legend Biotech LEGN Stock Holding History

Stifel Financial’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$444K	Sell	15,357 -11,397	-43%	-$307K	﹤0.01%	3039
2026 Q1	$484K	Sell	26,754 -128	-0.5%	-$2.44K	﹤0.01%	2903
2025 Q4	$584K	Sell	26,882 -8,137	-23%	-$233K	﹤0.01%	2779
2025 Q3	$1.14M	Buy	35,019 +1,544	+5%	+$57K	﹤0.01%	2319
2025 Q2	$1.19M	Buy	33,475 +654	+2%	+$21.2K	﹤0.01%	2223
2025 Q1	$1.11M	Buy	32,821 +1,456	+5%	+$52.2K	﹤0.01%	2154
2024 Q4	$1.02M	Buy	31,365 +12,955	+70%	+$537K	﹤0.01%	2223
2024 Q3	$897K	Sell	18,410 -3,635	-16%	-$194K	﹤0.01%	2304
2024 Q2	$976K	Buy	+22,045	New	+$1.02M	﹤0.01%	2181

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Stifel Financial's LEGN Position: Q2 2026 in Review

Stifel Financial reduced its Legend Biotech (LEGN) stake by 43% in Q2 2026, selling an estimated $307K and leaving 15,357 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

Stifel Financial first reported a position in LEGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.19M in Q2 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Stifel Financial held 15,357 shares of Legend Biotech worth $444K as of Q2 2026.
Stifel Financial sold 11,397 Legend Biotech shares in Q2 2026, an estimated $307K.
Legend Biotech made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3039 holding.
Stifel Financial first reported a position in Legend Biotech in Q2 2024 and has held it in 9 quarters since.
Stifel Financial's Legend Biotech position peaked at $1.19M in Q2 2025.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.